| Financier | Commitments |
|---|---|
| IDA Credit | 650.00 |
Nigeria Improved Child Survival Program for Human Capital MPA
Abstract*
The objective of the Immunization Plus and Malaria Progress by Accelerating Coverage and Transforming Services Project for Nigeria is to reduce under-five mortality rate in program areas. The Project has four components. 1. Malaria Control component will focus on: (a) Strengthening Service Delivery and (b) Health Systems Strengthening and Technical Assistance. 2. Immunization Plus component will additionally focus on (c) Vaccines, Cold Chain and Logistics... Show More
Development Objective
The project development objective (PDO) of the first phase (IMPACT) is to improve the utilization and quality of immunization plus and malaria services in selected states.
Key Details
Project Details
P167156
Active
Onoriode Ezire , Fatimah Ajus, Chijioke Okoro
Federal Republic of Nigeria
August 30, 2018
(as of board presentation)
February 18, 2020
February 17, 2021
US$ 650.00 million
Federal Ministry of Health,National Primary Health Care Development Agency (NPHCDA)
2020
US$ 650.00 million
B
June 24, 2024
December 31, 2025
Yes
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 650.00 |
| IBRD + IDA Commitment | 650.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 650.00 |
Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Jul 15, 2023 | IDA-65390 | Int Charges | 522,055.38 |
| Jul 15, 2023 | IDA-65390 | Int Charges | 847,568.70 |
| Jul 18, 2022 | IDA-65390 | Int Charges | 79,687.34 |
| Jul 18, 2022 | IDA-65390 | Int Charges | 79,687.34 |
| Jul 18, 2022 | IDA-65390 | Int Charges | 113,388.39 |
| Aug 8, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| Apr 11, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| Jul 25, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| May 24, 2022 | IDA-65390 | Loan Disb | 200,000.02 |
| Jun 3, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| Apr 8, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| Jul 12, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| May 31, 2022 | IDA-65390 | Loan Disb | -199,973.98 |
| Apr 22, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| Jul 27, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| Jul 27, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| Apr 12, 2023 | IDA-65390 | Loan Disb | 3,570,000.00 |
| Dec 12, 2022 | IDA-65390 | Loan Disb | 3,316,216.00 |
| Dec 15, 2022 | IDA-65390 | Loan Disb | 500,000.00 |
| Dec 8, 2022 | IDA-65390 | Loan Disb | 2,718,587.50 |
| Dec 8, 2022 | IDA-65390 | Loan Disb | 2,752,521.00 |
| Dec 8, 2022 | IDA-65390 | Loan Disb | 3,154,387.50 |
| Dec 8, 2022 | IDA-65390 | Loan Disb | 1,990,753.40 |
| Dec 9, 2022 | IDA-65390 | Loan Disb | 3,068,938.50 |
| Nov 4, 2022 | IDA-65390 | Loan Disb | 2,348,739.80 |
| Dec 8, 2022 | IDA-65390 | Loan Disb | 3,446,356.80 |
| Dec 8, 2022 | IDA-65390 | Loan Disb | 4,046,093.20 |
| Dec 8, 2022 | IDA-65390 | Loan Disb | 3,647,620.50 |
| Dec 12, 2022 | IDA-65390 | Loan Disb | 2,402,749.80 |
| Nov 14, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| Nov 30, 2022 | IDA-65390 | Loan Disb | 39,275.95 |
| Nov 30, 2022 | IDA-65390 | Loan Disb | 97,301.53 |
| Nov 30, 2022 | IDA-65390 | Loan Disb | 33,324.65 |
| Jul 29, 2022 | IDA-65390 | Loan Disb | 4,830,000.00 |
| Jun 30, 2022 | IDA-65390 | Loan Disb | 25,170,000.00 |
| Jun 14, 2022 | IDA-65390 | Loan Disb | 199,999.98 |
| Apr 14, 2022 | IDA-65390 | Loan Disb | 200,000.02 |
| Apr 14, 2022 | IDA-65390 | Loan Disb | 200,000.02 |
| Dec 5, 2022 | IDA-65390 | Loan Disb | 2,578,725.00 |
| Dec 5, 2022 | IDA-65390 | Loan Disb | 167,654.55 |
| Sep 27, 2022 | IDA-65390 | Loan Disb | 500,000.00 |
| Sep 1, 2022 | IDA-65390 | Loan Disb | 500,000.00 |
| Aug 2, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| Feb 11, 2022 | IDA-65390 | Loan Disb | 10,000,000.00 |
| Feb 11, 2022 | IDA-65390 | Loan Disb | 12,999,223.00 |
| May 11, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| May 11, 2022 | IDA-65390 | Loan Disb | 200,000.00 |
| May 24, 2024 | IDA-65390 | Loan Disb | 175,041.05 |
| Aug 1, 2024 | IDA-65390 | Loan Disb | 2,000,000.00 |
| Jul 15, 2024 | IDA-65390 | Int Charges | 989,864.50 |
| Jul 15, 2024 | IDA-65390 | Int Charges | 989,864.50 |
| Jul 15, 2024 | IDA-65390 | Int Charges | 1,636,642.10 |
| Feb 5, 2024 | IDA-65390 | Loan Disb | 349,414.90 |
| Mar 11, 2024 | IDA-65390 | Loan Disb | 1,155,898.40 |
| Mar 5, 2024 | IDA-65390 | Loan Disb | 7,733.00 |
| Feb 18, 2020 | IDA-65390 | Loan Commitment | 650,000,000.00 |
| Mar 20, 2024 | IDA-65390 | Loan Disb | 6,087,955.00 |
| Aug 9, 2024 | IDA-65390 | Loan Disb | 4,443,530.00 |
| Mar 8, 2024 | IDA-65390 | Loan Disb | 5,371,571.00 |
| May 2, 2024 | IDA-65390 | Loan Disb | 346,118.80 |
| Aug 20, 2024 | IDA-65390 | Loan Disb | 384,696.00 |
| Aug 13, 2024 | IDA-65390 | Loan Disb | 4,310,061.00 |
| Dec 12, 2023 | IDA-65390 | Loan Disb | 3,237,285.80 |
| Jan 16, 2024 | IDA-65390 | Loan Disb | 5,615,699.50 |
| Jan 16, 2024 | IDA-65390 | Loan Disb | 5,645,998.50 |
| Jan 10, 2024 | IDA-65390 | Loan Disb | 9,482,009.00 |
| Jan 11, 2024 | IDA-65390 | Loan Disb | 4,977,051.50 |
| Jan 11, 2024 | IDA-65390 | Loan Disb | 4,250,314.00 |
| Jan 12, 2024 | IDA-65390 | Loan Disb | 85,673.65 |
| Dec 21, 2023 | IDA-65390 | Loan Disb | 2,907,145.50 |
| Aug 6, 2024 | IDA-65390 | Loan Disb | 2,548,226.00 |
| Jul 15, 2024 | IDA-65390 | Int Charges | 29,142.67 |
| Jun 17, 2024 | IDA-65390 | Loan Disb | 715,280.25 |
| May 28, 2024 | IDA-65390 | Loan Disb | 750,997.10 |
| Feb 20, 2024 | IDA-65390 | Loan Disb | 237,696.70 |
| Apr 24, 2024 | IDA-65390 | Loan Disb | 355,724.20 |
| Apr 30, 2024 | IDA-65390 | Loan Disb | 500,000.00 |
| May 22, 2024 | IDA-65390 | Loan Disb | 351,487.70 |
| Jun 18, 2024 | IDA-65390 | Loan Disb | 400,603.75 |
| Feb 15, 2024 | IDA-65390 | Loan Disb | 2,456,912.50 |
| Jan 25, 2024 | IDA-65390 | Loan Disb | 4,621,870.00 |
| Feb 1, 2024 | IDA-65390 | Loan Disb | 5,725,811.50 |
| Jan 30, 2024 | IDA-65390 | Loan Disb | 1,200,524.00 |
| Feb 2, 2024 | IDA-65390 | Loan Disb | 117,520.00 |
| Jan 22, 2024 | IDA-65390 | Loan Disb | 3,753,585.50 |
| Jan 30, 2024 | IDA-65390 | Int Charges | 22,118.06 |
| Jan 30, 2024 | IDA-65390 | Int Charges | 635,575.94 |
| Jan 30, 2024 | IDA-65390 | Int Charges | 635,575.94 |
| Jan 30, 2024 | IDA-65390 | Int Charges | 1,030,087.75 |
| Sep 1, 2023 | IDA-65390 | Loan Disb | 10,352,171.00 |
| Sep 1, 2023 | IDA-65390 | Loan Disb | 4,782,254.50 |
| Jul 25, 2023 | IDA-65390 | Loan Disb | 4,018,464.00 |
| Sep 12, 2023 | IDA-65390 | Loan Disb | 1,000,000.00 |
| Sep 12, 2023 | IDA-65390 | Loan Disb | 1,705,566.00 |
| Sep 13, 2023 | IDA-65390 | Loan Disb | 584,337.06 |
| Jul 24, 2023 | IDA-65390 | Loan Disb | 411,800.00 |
| Jan 11, 2023 | IDA-65390 | Loan Disb | 665,000.00 |
| Jan 15, 2023 | IDA-65390 | Int Charges | 239,618.90 |
| Jan 15, 2023 | IDA-65390 | Int Charges | 239,618.90 |
| Jan 15, 2023 | IDA-65390 | Int Charges | 315,208.90 |
| Jan 15, 2023 | IDA-65390 | Int Charges | 19,913.16 |
| May 4, 2023 | IDA-65390 | Loan Disb | 2,338,034.80 |
| Feb 24, 2023 | IDA-65390 | Loan Disb | 2,902,543.00 |
| Feb 7, 2023 | IDA-65390 | Loan Disb | 42,995,216.00 |
| Jan 9, 2024 | IDA-65390 | Loan Disb | 7,340,782.50 |
| Jan 9, 2024 | IDA-65390 | Loan Disb | 22,620,180.00 |
| May 23, 2023 | IDA-65390 | Loan Disb | 1,916,138.10 |
| Jun 5, 2023 | IDA-65390 | Loan Disb | 1,795,060.00 |
| Jul 19, 2023 | IDA-65390 | Loan Disb | 1,000,000.00 |
| Jul 15, 2023 | IDA-65390 | Int Charges | 84,536.68 |
| Jul 15, 2023 | IDA-65390 | Int Charges | 522,055.38 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-12-24 |
| Project Management | Satisfactory | 2024-12-24 |
| Monitoring and Evaluation | Satisfactory | 2024-12-24 |
| Overall Implementation Progress (IP) | Satisfactory | 2024-12-24 |
| Financial Management | Moderately Satisfactory | 2024-12-24 |
| Progress towards achievement of PDO | Moderately Satisfactory | 2024-12-24 |
| Procurement | Moderately Satisfactory | 2024-12-24 |
| Financial Management | Moderately Satisfactory | 2024-12-24 |
| Procurement | Moderately Satisfactory | 2024-12-24 |
| Project Management | Moderately Satisfactory | 2024-12-24 |
| Progress towards achievement of PDO | Satisfactory | 2024-12-24 |
| Monitoring and Evaluation | Satisfactory | 2024-12-24 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of children under five sleeping under Long-Lasting Insecticide Nets (LLINs) the night prior to the survey Value 28.50 41.20 41.00 Date December 31, 2019 August 8, 2022 December 31, 2025 Comment Under-five mortality rate Value 132.00 132.00 112.00 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Percentage of children ages (12-23) months vaccinated with third dose of Pentavalent Vaccine Value 48.70 56.60 64.40 Date December 31, 2019 August 8, 2022 December 31, 2025 Comment Average Health Facility Quality of Care Score Value 34.30 34.30 59.30 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Percentage girls under-five who slept under Long-Lasting Insecticide Nets (LLINs) the night prior to the survey Value 29.10 29.10 31.50 Date Comment Percentage girls ages (12-23) months vaccinated with third dose of Pentavalent Vaccine Value 42.80 42.80 47.10 Date Comment Percentage of febrile children under five in the last two weeks who were treated with ACTs Value 32.40 32.40 42.40 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Percentage of children ages (12-23) months vaccinated with third dose of Pneumococcal Vaccine (will be disaggregated by gender) Value 46.60 46.60 63.30 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Percentage of women (15-49) who had live births in the 2 years preceding the survey who were assisted by a skilled birth attendant during delivery Value 45.10 45.10 52.60 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Percentage febrile girls under-five in the last two weeks who were treated with ACTs Value 30.70 30.70 33.00 Date Comment Percentage of women (15-49) receiving a postnatal checkup within 2 days of delivery among respondents who had a birth in the 2 years preceding the survey Value 47.70 47.70 55.20 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of pregnant women who received three or more doses of IPT during antenatal care Value 8.10 8.10 20.00 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Semi-annual nationwide LQAS surveys conducted and disclosed publicly Value 0.00 5.00 10.00 Date December 31, 2019 June 7, 2024 December 31, 2025 Comment Percentage of facilities receiving DFF with engagement of ward development committee for facility management Value 0.00 100.00 80.00 Date December 31, 2019 October 26, 2023 December 31, 2025 Comment Percentage of Primary Health Facility Health Workers who have Knowledge of IMCI Key danger signs and main symptoms in malaria states Value 45.40 45.40 55.40 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Percentage of facilities where a copy of the checklist was left at the facility for the most recent ISS visit Value 16.20 16.20 41.20 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Percentage of public health facilities with safe disposal of sharps waste in immunization plus states Value 26.50 26.50 41.50 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Percentage of children under 5 with fever in the last two weeks who had had blood taken from a finger or heel for testing in malaria control states Value 18.50 18.50 31.00 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Percentage of children ages (12-23) months vaccinated with the 3rd dose of Pentavalent Vaccine in bottom two quintiles Value 18.40 18.40 49.20 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Percentage of public health facilities with safe disposal of sharps waste in malaria states Value 46.40 46.40 61.40 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment Proportion of annual vaccine procurement expenditure released from government budgetary resources Value 28.00 73.00 60.00 Date December 31, 2019 October 20, 2023 December 31, 2025 Comment Percentage increase in performance framework score of federal and state PIUs in malaria states Value 0.00 50.00 50.00 Date December 31, 2019 June 7, 2024 December 31, 2025 Comment Percentage increase in performance framework score of federal and state PIUs in immunization plus states Value 0.00 50.00 50.00 Date December 31, 2019 June 7, 2024 December 31, 2025 Comment Primary Health Facility Health Workers’ Knowledge of IMCI Key danger signs and main symptoms in immunization plus states Value 48.00 48.00 58.00 Date December 31, 2019 August 12, 2022 December 31, 2025 Comment People who have received essential health, nutrition, and population (HNP) services Value 0.00 13602739.00 8000000.00 Date December 31, 2019 April 30, 2024 December 31, 2025 Comment People who have received essential health, nutrition, and population (HNP) services - Female (RMS requirement) Value 0.00 0.00 1000000.00 Date Comment Number of children immunized Value 0.00 9908233.00 6000000.00 Date December 31, 2019 April 30, 2024 December 31, 2025 Comment Number of deliveries attended by skilled health personnel Value 0.00 3694506.00 2000000.00 Date December 31, 2019 April 30, 2024 December 31, 2025 Comment